SMAD3 and hepatocellular carcinoma: In addition, Fu et al. [57] demonstrated the presence of SMAD3-rich EVs in the peripheral blood of HCC patients, which exhibited a positive correlation with disease stage, tumor adhesion, pathological severity, and prognosis.